ADPT vs NUE · rev $142.4M vs P/E 25, rev $19.89B
Adaptive Biotechnologies Corp (ADPT) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
ADPT currently screens at market cap $2.69B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the ADPT and NUE stock pages for the full models.
Not investment advice.